Early ribavirin reduce RSV symptoms duration in post-allogeneic stem cell transplant: challenges in symptoms duration assessment

This publication has 11 references indexed in Scilit:

• Community-Acquired Respiratory Virus Infections: A Threat to Long-Term Survivors After Allogeneic Stem Cell Transplant?
  Clinical Infectious Diseases, 2024
• Inter and intra-host diversity of RSV in hematopoietic stem cell transplant adults with normal and delayed viral clearance
  Virus Evolution, 2023
• Prognostic factors for the development of lower respiratory tract infection after influenza virus infection in allogeneic hematopoietic stem cell transplantation recipients: A Kanto Study Group for Cell Therapy multicenter analysis
  International Journal of Infectious Diseases, 2023
• Systematic literature review of the signs and symptoms of respiratory syncytial virus
  Influenza and Other Respiratory Viruses, 2023
• The Successes and Challenges of SARS-CoV-2 Molecular Testing in the United States
  Clinics In Laboratory Medicine, 2022
• The systemic immunosuppressive effects of peripheral corticosteroid injections: A narrative review of the evidence in the context of COVID‐19
  Musculoskeletal Care, 2021
• Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study
  European Respiratory Journal, 2020
• Comparison of respiratory virus shedding by conventional and molecular testing methods in patients with haematological malignancy
  Clinical Microbiology and Infection, 2016
• Long-Term Shedding of Influenza Virus, Parainfluenza Virus, Respiratory Syncytial Virus and Nosocomial Epidemiology in Patients with Hematological Disorders
  PLOS ONE, 2016
• Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients
  Blood, 2010